ISEE Insider Trading Activity and SEC Form 4 Filings
ISEE insider trading summary
No open-market insider purchases or sales of IVERIC bio, Inc. (ISEE) have been reported on SEC Form 4 in the past 12 months.
Latest ISEE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 3, 2023 | Keith Westby | SVP, Chief Operating Officer | Sell | $789K (20,000 @ $39.45) |
| Jun 2, 2023 | Keith Westby | SVP, Chief Operating Officer | Sell | $757K (20,000 @ $37.87) |
| May 2, 2023 | Keith Westby | SVP, Chief Operating Officer | Sell | $756K (20,000 @ $37.81) |
| May 1, 2023 | Keith Westby | SVP, Chief Operating Officer | Sell | $326K (8,786 @ $37.12) |
| May 1, 2023 | Keith Westby | SVP, Chief Operating Officer | Sell | $416K (11,214 @ $37.12) |
| May 1, 2023 | David Francis Carroll | SVP, Chief Financial Officer | Sell | $2.4M (63,500 @ $37.04) |
| Apr 24, 2023 | David Francis Carroll | SVP, Chief Financial Officer | Sell | $1.5M (48,171 @ $30.21) |
| Apr 24, 2023 | Keith Westby | SVP, Chief Operating Officer | Sell | $565K (18,782 @ $30.07) |
| Apr 21, 2023 | David Francis Carroll | SVP, Chief Financial Officer | Sell | $55K (1,829 @ $30.00) |
| Apr 21, 2023 | Keith Westby | SVP, Chief Operating Officer | Sell | $37K (1,218 @ $30.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.